HIV vaccine - BioNTech
Latest Information Update: 28 Jul 2024
At a glance
- Originator BioNTech
- Class AIDS vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in Germany (Parenteral)
- 04 Jul 2022 HIV vaccine - BioNTech is available for licensing as of 27 Jun 2022. https://www.biontech.com/int/en/home/about/collaborators.html
- 27 Jun 2022 Preclinical development is still ongoing for HIV infections in Germany ((BioNtech pipeline, June 2022)